Avalere Solution Helps Plans Drive Change with Cross-Benefit Analytics and Industry Expertise

Avalere is excited to announce Plan Economics and Performance, an industry-leading solution comprised of advanced analytics and subject matter expertise to give plans an integrated, cross-benefit view of their pharmacy business and insight into how members’ pharmacy spend, when combined with co-morbidity profile, impacts total costs and utilization.

Our Plan Economics and Performance solution was developed to provide a flexible, cost-effective way for our clients to stay on top of the rapidly changing Part D landscape and to develop strategies to help them compete in an increasingly unpredictable and financially constrained business environment. Avalere has helped clients estimate the potential impact of Part D Redesign on Medicare Advantage Prescription Drug (MA-PD) plans and Prescription Drug Plan (PDP) programs’ drug costs, influence provider prescribing behavior, and develop formulary strategies to reduce the total cost of care.

We invite you to put one of the industry’s most respected research teams to work for you. Avalere offers tremendous flexibility in how we engage with clients, so if you’re looking for a business partner to do all of the heavy lifting, need third-party analytics to pressure-test your internal estimates or anything in between—we can help fill the gap.?

Learn more about how Avalere has used Plan Economics and Performance to support clients or connect with an expert .